PyInvesting

Market research

9776.TSE Sapporo Clinical Laboratory Inc

TSE JPY Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
35K
P/E ratio
0.0
Analyst target
Not available
Dividend yield
1.2%
Beta
0.35

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Sapporo Clinical Laboratory Inc is currently in a long term uptrend where the price is trading 5.7% above its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.

Sapporo Clinical Laboratory Inc's total revenue rose by 2.5% to $5B since the same quarter in the previous year.

Its net income has increased by 52.0% to $258M since the same quarter in the previous year.

Based on the above factors, Sapporo Clinical Laboratory Inc gets an overall score of 4/5.